Identification of Helicobacter pylori VacA in human lung and its effects on lung cells

Biochemical and Biophysical Research Communications

Volumn 460, Issue 3, 2015, Pages 721-726

  Nakashima, Shota ^a   Kakugawa, Tomoyuki ^a   Yura, Hirokazu ^a   Tomonaga, Masaomi ^a   Harada, Tatsuhiko ^a   Hara, Atsuko ^a   Hara, Shintaro ^a   Nakano, Masayuki ^b   Yamasaki, Eiki ^c   Sakamoto, Noriho ^a   Ishimatsu, Yuji ^a   Isomoto, Hajime ^d   Gochuico, Bernadette R ^e   Suffredini, Anthony F ^f   Mukae, Hiroshi ^g   Kurazono, Hisao ^c   Hirayama, Toshiya ^b   Moss, Joel ^f   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

^c OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

^d NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^e NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

^g UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

A549 cells; Helicobacter pylori; Interleukin 6; Interleukin 8; Normal human bronchial epithelial cells; VacA

Indexed keywords

BACTERIAL PROTEIN; CYTOKINE; VACA PROTEIN, HELICOBACTER PYLORI;

ADULT; AGED; BIOSYNTHESIS; CELL CULTURE; FEMALE; HELICOBACTER PYLORI; HUMAN; ISOLATION AND PURIFICATION; LUNG; MALE; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ADULT; AGED; BACTERIAL PROTEINS; CELL LINE, TUMOR; CELLS, CULTURED; CYTOKINES; FEMALE; HELICOBACTER PYLORI; HUMANS; LUNG; MALE; MIDDLE AGED;

EID: 84937765224     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.03.096     Document Type: Article

References (36)

1. M. Asaka, M. Kato, S. Takahashi, et al. Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition Helicobacter 15 2010 1 20
2. K.W. Tsang, S.K. Lam, W.K. Lam, et al. High seroprevalence of Helicobacter pylori in active bronchiectasis Am. J. Respir. Crit. Care Med. 158 1998 1047 1051
3. M. Caselli, E. Zaffoni, M. Ruina, et al. Helicobacter pylori and chronic bronchitis Scand. J. Gastroenterol. 34 1999 828 830
4. D. Bennett, E. Bargagli, R.M. Refini, et al. Helicobacter pylori seroprevalence in patients with idiopathic pulmonary fibrosis Eur. Respir. J. 43 2014 635 638
5. M. Gulhan, E. Ozyilmaz, G. Tarhan, et al. Helicobacter pylori in bronchiectasis: a polymerase chain reaction assay in bronchoalveolar lavage fluid and bronchiectatic lung tissue Arch. Med. Res. 38 2007 317 321
6. J. Angrill, N. Sanchez, C. Agusti, et al. Does Helicobacter pylori have a pathogenic role in bronchiectasis? Respir. Med. 100 2006 1202 1207
7. S.L. Palframan, T. Kwok, and K. Gabriel Vacuolating cytotoxin A (VacA), a key toxin for Helicobacter pylori pathogenesis Front. Cell. Infect. Microbiol. 2 2012 92
8. I.J. Kim, and S.R. Blanke Remodeling the host environment: modulation of the gastric epithelium by the Helicobacter pylori vacuolating toxin (VacA) Front. Cell. Infect. Microbiol. 2 2012 37
9. M.G. Chambers, T.M. Pyburn, C. Gonzalez-Rivera, et al. Structural analysis of the oligomeric states of Helicobacter pylori VacA toxin J. Mol. Biol. 425 2013 524 535
10. American Thoracic Society/European respiratory society International Multidisciplinary consensus Classification of the idiopathic interstitial pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001 Am. J. Respir. Crit. Care Med. 165 2002 277 304
11. K. Yahiro, T. Niidome, T. Hatakeyama, et al. Helicobacter pylori vacuolating cytotoxin binds to the 140-kDa protein in human gastric cancer cell lines, AZ-521 and AGS Biochem. Biophys. Res. Commun. 238 1997 629 632
12. M. Nakayama, J. Hisatsune, E. Yamasaki, et al. Clustering of Helicobacter pylori VacA in lipid rafts, mediated by its receptor, receptor-like protein tyrosine phosphatase beta, is required for intoxication in AZ-521 Cells Infect. Immun. 74 2006 6571 6580
13. K. Yahiro, T. Niidome, and M. Kimura Activation of Helicobacter pylori VacA toxin by alkaline or acid conditions increases its binding to a 250-kDa receptor protein-tyrosine phosphatase beta J. Biol. Chem. 274 1999 36693 36699
14. J.R. Belcher The pulmonary complications of dysphagia Thorax 4 1949 44 56
15. M.P. Sweet, M.G. Patti, C. Hoopes, et al. Gastro-oesophageal reflux and aspiration in patients with advanced lung disease Thorax 64 2009 167 173
16. J.S. Lee, H.R. Collard, G. Raghu, et al. Does chronic microaspiration cause idiopathic pulmonary fibrosis? Am. J. Med. 123 2010 304 311
17. J.S. Lee, J.W. Song, P.J. Wolters, et al. Bronchoalveolar lavage pepsin in acute exacerbation of idiopathic pulmonary fibrosis Eur. Respir. J. 39 2012 352 358
18. S. Farrell, C. McMaster, D. Gibson, et al. Pepsin in bronchoalveolar lavage fluid: a specific and sensitive method of diagnosing gastro-oesophageal reflux-related pulmonary aspiration J. Pediatr. Surg. 41 2006 289 293
19. P. McNally, E. Ervine, M.D. Shields, et al. High concentrations of pepsin in bronchoalveolar lavage fluid from children with cystic fibrosis are associated with high interleukin-8 concentrations Thorax 66 2011 140 143
20. R. Stovold, I.A. Forrest, P.A. Corris, et al. Pepsin, a biomarker of gastric aspiration in lung allografts: a putative association with rejection Am. J. Respir. Crit. Care Med. 175 2007 1298 1303
21. C. Ward, I.A. Forrest, I.A. Brownlee, et al. Pepsin like activity in bronchoalveolar lavage fluid is suggestive of gastric aspiration in lung allografts Thorax 60 2005 872 874
22. F. D'Ovidio, M. Mura, M. Tsang, et al. Bile acid aspiration and the development of bronchiolitis obliterans after lung transplantation J. Thorac. Cardiovasc Surg. 129 2005 1144 1152
23. V. Starosta, R. Kitz, D. Hartl, et al. Bronchoalveolar pepsin, bile acids, oxidation, and inflammation in children with gastroesophageal reflux disease Chest 132 2007 1557 1564
24. J.S. Lee, H.R. Collard, K.J. Anstrom, et al. Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials Lancet Respir. Med. 1 2013 369 376
25. J.S. Lee, J.H. Ryu, B.M. Elicker, et al. Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis Am. J. Respir. Crit. Care Med. 184 2011 1390 1394
26. P.S. Anand, K.P. Kamath, and S. Anil Role of dental plaque, saliva and periodontal disease in Helicobacter pylori infection World J. Gastroenterol. 20 2014 5639 5653
27. D.S. Smyk, A.L. Koutsoumpas, M.G. Mytilinaiou, et al. Helicobacter pylori and autoimmune disease: cause or bystander World J. Gastroenterol. 20 2014 613 629
28. M.R. Huber, S. Kumar, and A. Tefferi Treatment advances in adult immune thrombocytopenic purpura Ann. Hematol. 82 2003 723 737
29. A. Gasbarrini, I. Massari, M. Serricchio, et al. Helicobacter pylori eradication ameliorates primary Raynaud's phenomenon Dig. Dis. Sci. 43 1998 1641 1645
30. G. Bertalot, G. Montresor, M. Tampieri, et al. Decrease in thyroid autoantibodies after eradication of Helicobacter pylori infection Clin. Endocrinol. (Oxf) 61 2004 650 652
31. T.J. Richards, N. Kaminski, F. Baribaud, et al. Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis Am. J. Respir. Crit. Care Med. 185 2012 67 76
32. Y. Fujimori, M. Kataoka, S. Tada, et al. The role of interleukin-8 in interstitial pneumonia Respirology 8 2003 33 40
33. J. Angrill, C. Agusti, R. De Celis, et al. Bronchial inflammation and colonization in patients with clinically stable bronchiectasis Am. J. Respir. Crit. Care Med. 164 2001 1628 1632
34. Y.P. Moodley, N.L. Misso, A.K. Scaffidi, et al. Inverse effects of interleukin-6 on apoptosis of fibroblasts from pulmonary fibrosis and normal lungs Am. J. Respir. Cell. Mol. Biol. 29 2003 490 498
35. D.A. Knight, M. Ernst, G.P. Anderson, et al. The role of gp130/IL-6 cytokines in the development of pulmonary fibrosis: critical determinants of disease susceptibility and progression? Pharmacol. Ther. 99 2003 327 338
36. M. Yoshida, J. Sakuma, S. Hayashi, et al. A histologically distinctive interstitial pneumonia induced by overexpression of the interleukin 6, transforming growth factor beta 1, or platelet-derived growth factor B gene Proc. Natl. Acad. Sci. U S A 92 1995 9570 9574